Stay updated on Daratumumab in Bortezomib Combo for Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Bortezomib Combo for Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Bortezomib Combo for Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page header. This is a minor UI update with no impact on study data.
    Difference
    0.0%
    Check dated 2026-03-12T21:34:13.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new site revision entry (Revision: v3.4.2) was added, and older notices (the funding lapse notice and Revision: v3.4.1) were removed.
    Difference
    0.3%
    Check dated 2026-02-11T02:47:27.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A system-wide notice about funding status and the NIH Clinical Center's status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T00:43:33.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A glossary toggle was added and the history view now uses green for additions and red for deletions with an accompanying legend; the revision tag was updated from v3.3.4 to v3.4.0.
    Difference
    0.4%
    Check dated 2026-01-28T00:24:44.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.4, replacing v3.3.3; this is a cosmetic/versioning change that does not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:32:11.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the history and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T10:17:05.000Z thumbnail image

Stay in the know with updates to Daratumumab in Bortezomib Combo for Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Bortezomib Combo for Myeloma Clinical Trial page.